Announced Tue, 1 Jul · 15:50 IST

Appointment of the Company Secretary and Compliance Officer of the Company

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ganga Pharmaceuticals Ltd has announced the appointment of a new Company Secretary and Compliance Officer. This is a key managerial personnel (KMP) appointment under the Companies Act. The Company Secretary is responsible for ensuring regulatory compliance, board coordination, and shareholder communications. The filing was made to BSE to keep the stock exchange and stakeholders informed of this leadership change. No other board-level changes were mentioned in this announcement.

Likely market impact

This is a routine governance update and is not expected to materially impact the stock price. It confirms that the company has fulfilled its compliance requirement of having a designated Compliance Officer in place.